Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA (COSIRA)

This study has been completed.
Information provided by (Responsible Party):
Neovasc Inc. Identifier:
First received: September 13, 2010
Last updated: November 22, 2013
Last verified: November 2013